Deborah A. Robins
- Endocrinology, Diabetes and Metabolism top 0.5%
- Molecular Biology top 10%
- Pharmacology top 1%
- Physiology top 5%
- Surgery top 5%
- Co-authors
- Axel HauptCharles BensonXuewei CuiZvonko MiličevićJuan P. FríasKevin L. DuffinMichael A. NauckShweta Urva
- Topics
- Diabetes Treatment and Management (13 papers)Metabolism, Diabetes, and Cancer (9 papers)Pharmacology and Obesity Treatment (6 papers)
- Partner nations
- United StatesSingaporeJapan
In The Last Decade
Deborah A. Robins
25 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Endocrinology, Diabetes and Metabolism 1.8k
- Molecular Biology 974
- Pharmacology 650
- Physiology 629
- Surgery 622
Countries citing papers authored by Deborah A. Robins
This map shows the geographic impact of Deborah A. Robins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah A. Robins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah A. Robins more than expected).
Fields of papers citing papers by Deborah A. Robins
This network shows the impact of papers produced by Deborah A. Robins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah A. Robins. The network helps show where Deborah A. Robins may publish in the future.
Co-authorship network of co-authors of Deborah A. Robins
This figure shows the co-authorship network connecting the top 25 collaborators of Deborah A. Robins. A scholar is included among the top collaborators of Deborah A. Robins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah A. Robins. Deborah A. Robins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosisbreakdown → | 353 |
| 3 | 0 | |
| 4 | 23 | |
| 5 | 34 | |
| 6 | Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 studybreakdown → | 97 |
| 7 | 52 | |
| 8 | Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesitybreakdown → | 259 |
| 9 | 2 | |
| 10 | 89 | |
| 11 | 171 | |
| 12 | 113 | |
| 13 | 220 | |
| 14 | Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetesbreakdown → | 271 |
| 15 | 5 | |
| 16 | Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trialbreakdown → | 610 |
| 17 | 14 | |
| 18 | 216 | |
| 19 | 6 | |
| 20 | 19 |
About Deborah A. Robins
Deborah A. Robins is a scholar working on Endocrinology, Diabetes and Metabolism, Orthopedics and Sports Medicine and Pharmacology, having authored 27 papers that have together received 2.7k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (13 papers), Metabolism, Diabetes, and Cancer (9 papers) and Pharmacology and Obesity Treatment (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.8k citations), Pharmacology (650 citations) and Physiology (629 citations). Deborah A. Robins has collaborated with scholars based in United States, Singapore and Japan. Frequent co-authors include Axel Haupt, Charles Benson, Xuewei Cui, Zvonko Miličević, Juan P. Frías, Kevin L. Duffin, Michael A. Nauck, Shweta Urva, Joanna Van and Ross Bray. Their work appears in journals such as New England Journal of Medicine, The Lancet and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.